China Gestalt Technology Completes 420 Million Yuan Angel+ Round and Launches Shanghai Headquarters

en.Wedoany.com Reported - On July 3, China's brain-computer interface company Gestalt Technology announced the completion of a 420 million yuan Angel+ financing round. This round was led by Huaying Capital, with participation from C Capital, Sequoia Capital China, Lens Technology, CEC Health Fund, Sinovation Ventures, Lingang Science and Technology Innovation Investment, Fudan Furong Capital, and Guotai Venture Capital, among others. Existing investors such as DT Capital, Yunshi Capital, Qingsong Capital, and Gobi Partners also increased their investments. On the same day, Gestalt Technology's Shanghai headquarters officially opened in the "Brain Intelligence World" area of Minhang District, Shanghai, establishing a dual-headquarters layout of "Chengdu + Shanghai."

Gestalt Technology's core business is ultrasonic brain-computer interfaces. Compared to common electrical signal acquisition methods, ultrasonic brain-computer interfaces emphasize non-invasive brain signal reading and writing, neural circuit regulation, and multi-target action capabilities. Target application areas include chronic pain, depression, Alzheimer's disease, Parkinson's disease, stroke rehabilitation, epilepsy, and other neurological conditions. To enter medical and rehabilitation scenarios, brain-computer interface products must simultaneously overcome challenges in device development, algorithm modeling, clinical validation, ethical compliance, data security, and doctor workflow integration. With this financing, Gestalt Technology will use the funds to support the expansion of its R&D team, construction of experimental platforms, advancement of clinical collaborations, and preparation for industrialization, while maintaining a high level of investment in the ultrasonic brain-computer interface track.

Following the launch of its Shanghai headquarters, Gestalt Technology now operates two hubs: Chengdu and Shanghai. The Chengdu hub is closer to the company's early development and accumulation of research resources, while the Shanghai hub is near brain science, medical innovation, capital institutions, and industrial collaboration resources. The "Brain Intelligence World" area in Minhang District is gathering brain science, brain-inspired intelligence, medical technology, and hard-tech companies. By locating its Shanghai headquarters here, Gestalt Technology can better connect with research institutions like Fudan University, clinical resources, industrial funds, and the Yangtze River Delta's medical device supply chain.

The structure of this round's investors also reveals Gestalt Technology's direction for industrial expansion. Institutions such as Huaying Capital, Sequoia Capital China, and Sinovation Ventures represent hard-tech and AI investment forces; CEC Health Fund and Qingsong Capital are closer to the healthcare industry; Lens Technology brings precision manufacturing and hardware industry expertise; and Lingang Science and Technology Innovation Investment, Fudan Furong Capital, and Guotai Venture Capital are strongly tied to Shanghai's local innovation resources. Brain-computer interface products cannot remain as laboratory prototypes; they require support from sensors, acoustic components, algorithm platforms, data systems, medical device engineering, quality systems, and clinical scenarios. With the involvement of diverse investors, Gestalt Technology will gain not only capital but also industrial resources, application scenarios, and engineering collaboration opportunities.

Gestalt Technology has maintained a rapid financing pace this year. The company previously completed a 150 million yuan Angel round, and this Angel+ round reached 420 million yuan, indicating that ultrasonic brain-computer interfaces are becoming a highly watched technology route in the brain-computer interface industry. Overseas markets already have companies exploring ultrasonic neural regulation and novel brain-computer interfaces. For Chinese companies to compete in this direction, they must simultaneously advance basic research, medical translation, device engineering, and algorithm systems. For Gestalt Technology, the launch of its Shanghai headquarters and the completion of this new financing round will propel the company from an early-stage team-building phase into a more systematic phase of R&D, translation, and industrial collaboration.